Home / News / India News / Article / NTAGI to review data of Covid-19 vaccines for children aged 5-12 years: Sources

NTAGI to review data of Covid-19 vaccines for children aged 5-12 years: Sources

Recently, the Drugs Controller General of India (DCGI) granted emergency use authorization to Biological E's Corbevax for children in the age bracket of 5 to 12 years and Bharat Biotech's Covaxin for kids aged 6 to 12 years

Listen to this article :
Representative  image

Representative image

The Covid-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review the data of Covid-19 vaccines for the children aged 5 to 12 years on May 4, said sources on Monday.

"After looking into the safety and efficacy data of the vaccines, the second level Standing Technical Sub-Committee (STSC) will review and discuss the recommendations by the working group. The STSC will again review the data and then give their decision to the final group of NTAGI that will take the final call," said sources.

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement